Sharps Compliance Corp.
Sharps Compliance Corp. Fundamental Analysis
Sharps Compliance Corp. (SMED) shows moderate financial fundamentals with a PE ratio of 11.58, profit margin of 16.84%, and ROE of 33.79%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 76.8/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze SMED's fundamental strength across five key dimensions:
Efficiency Score
ExcellentSMED demonstrates superior asset utilization.
Valuation Score
ExcellentSMED trades at attractive valuation levels.
Growth Score
ModerateSMED shows steady but slowing expansion.
Financial Health Score
ExcellentSMED maintains a strong and stable balance sheet.
Profitability Score
ModerateSMED maintains healthy but balanced margins.
Key Financial Metrics
Is SMED Expensive or Cheap?
P/E Ratio
SMED trades at 11.58 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, SMED's PEG of 0.12 indicates potential undervaluation.
Price to Book
The market values Sharps Compliance Corp. at 3.20 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 0.87 times EBITDA. This is generally considered low.
How Well Does SMED Make Money?
Net Profit Margin
For every $100 in sales, Sharps Compliance Corp. keeps $16.84 as profit after all expenses.
Operating Margin
Core operations generate 16.10 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $33.79 in profit for every $100 of shareholder equity.
ROA
Sharps Compliance Corp. generates $17.06 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $1.12 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
11.58
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.12
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.20
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.29
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.63
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.34
vs 25 benchmark
ROA
Return on assets percentage
0.17
vs 25 benchmark
ROCE
Return on capital employed
0.21
vs 25 benchmark
How SMED Stacks Against Its Sector Peers
| Metric | SMED Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 11.58 | 26.66 | Better (Cheaper) |
| ROE | 33.79% | 1305.00% | Weak |
| Net Margin | 16.84% | -5148.00% (disorted) | Strong |
| Debt/Equity | 0.29 | 0.82 | Strong (Low Leverage) |
| Current Ratio | 2.63 | 10.84 | Strong Liquidity |
| ROA | 17.06% | -1553219.00% (disorted) | Strong |
SMED outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Sharps Compliance Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
EPS CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
FCF CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure